Balyasny Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Balyasny Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,202,733	Closed	-$42.5M	–	3113
2023 Q1	$29.3M	Buy	1,202,733 +359,422	+43%	+$7.87M	0.07%	388
2022 Q4	$18.1M	Sell	843,311 -839,924	-50%	-$17.9M	0.05%	526
2022 Q3	$30.2M	Buy	1,683,235 +1,180,342	+235%	+$15.5M	0.09%	293
2022 Q2	$4.84M	Buy	+502,893	New	+$6.31M	0.02%	953
2022 Q1	–	Sell	-33,628	Closed	-$562K	–	2994
2021 Q4	$562K	Buy	+33,628	New	+$551K	﹤0.01%	1593
2016 Q2	–	Sell	-50,696	Closed	-$2.14M	–	1519
2016 Q1	$2.14M	Sell	50,696 -115,195	-69%	-$5.87M	0.01%	681
2015 Q4	$13M	Sell	165,891 -143,311	-46%	-$8.29M	0.09%	304
2015 Q3	$12.5M	Buy	309,202 +211,883	+218%	+$11.2M	0.09%	288
2015 Q2	$5.07M	Buy	+97,319	New	+$4.84M	0.03%	584

Balyasny Asset Management's ISEE Position: Q2 2023 in Review

Balyasny Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 1,202,733 shares — an estimated $42.5M sold.

Balyasny Asset Management first reported a position in ISEE in Q2 2015 and held it in 9 quarters. The position peaked at $30.2M in Q3 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Balyasny Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 1,202,733 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $42.5M.
Balyasny Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 9 quarters.
Balyasny Asset Management's IVERIC bio, Inc. Common Stock position peaked at $30.2M in Q3 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.